These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 26657155)
1. Overexpression of GAB2 in ovarian cancer cells promotes tumor growth and angiogenesis by upregulating chemokine expression. Duckworth C; Zhang L; Carroll SL; Ethier SP; Cheung HW Oncogene; 2016 Aug; 35(31):4036-47. PubMed ID: 26657155 [TBL] [Abstract][Full Text] [Related]
2. AKIP1 promotes angiogenesis and tumor growth by upregulating CXC-chemokines in cervical cancer cells. Zhang W; Wu Q; Wang C; Yang L; Liu P; Ma C Mol Cell Biochem; 2018 Nov; 448(1-2):311-320. PubMed ID: 29520695 [TBL] [Abstract][Full Text] [Related]
3. Elevated Gab2 induces tumor growth and angiogenesis in colorectal cancer through upregulating VEGF levels. Ding C; Luo J; Fan X; Li L; Li S; Wen K; Feng J; Wu G J Exp Clin Cancer Res; 2017 Apr; 36(1):56. PubMed ID: 28420432 [TBL] [Abstract][Full Text] [Related]
4. Gab2 promotes cancer stem cell like properties and metastatic growth of ovarian cancer via downregulation of miR-200c. Fang Z; Li T; Chen W; Wu D; Qin Y; Liu M; Wu G; He L; Li H; Gu H Exp Cell Res; 2019 Sep; 382(1):111462. PubMed ID: 31194976 [TBL] [Abstract][Full Text] [Related]
5. Gab2 regulates the migratory behaviors and E-cadherin expression via activation of the PI3K pathway in ovarian cancer cells. Wang Y; Sheng Q; Spillman MA; Behbakht K; Gu H Oncogene; 2012 May; 31(20):2512-20. PubMed ID: 21996746 [TBL] [Abstract][Full Text] [Related]
6. IKKβ targeting reduces KRAS-induced lung cancer angiogenesis in vitro and in vivo: A potential anti-angiogenic therapeutic target. Carneiro-Lobo TC; Scalabrini LC; Magalhães LDS; Cardeal LB; Rodrigues FS; Dos Santos EO; Baldwin AS; Levantini E; Giordano RJ; Bassères DS Lung Cancer; 2019 Apr; 130():169-178. PubMed ID: 30885340 [TBL] [Abstract][Full Text] [Related]
7. In vivo multiplexed interrogation of amplified genes identifies GAB2 as an ovarian cancer oncogene. Dunn GP; Cheung HW; Agarwalla PK; Thomas S; Zektser Y; Karst AM; Boehm JS; Weir BA; Berlin AM; Zou L; Getz G; Liu JF; Hirsch M; Vazquez F; Root DE; Beroukhim R; Drapkin R; Hahn WC Proc Natl Acad Sci U S A; 2014 Jan; 111(3):1102-7. PubMed ID: 24385586 [TBL] [Abstract][Full Text] [Related]
8. GABARBP down-regulates HIF-1α expression through the VEGFR-2 and PI3K/mTOR/4E-BP1 pathways. Park SH; Kim BR; Lee JH; Park ST; Lee SH; Dong SM; Rho SB Cell Signal; 2014 Jul; 26(7):1506-13. PubMed ID: 24686084 [TBL] [Abstract][Full Text] [Related]
9. The chemokine CXCL1 induces proliferation in epithelial ovarian cancer cells by transactivation of the epidermal growth factor receptor. Bolitho C; Hahn MA; Baxter RC; Marsh DJ Endocr Relat Cancer; 2010 Dec; 17(4):929-40. PubMed ID: 20702723 [TBL] [Abstract][Full Text] [Related]
10. Progesterone and calcitriol attenuate inflammatory cytokines CXCL1 and CXCL2 in ovarian and endometrial cancer cells. Kavandi L; Collier MA; Nguyen H; Syed V J Cell Biochem; 2012 Oct; 113(10):3143-52. PubMed ID: 22615136 [TBL] [Abstract][Full Text] [Related]
11. CXCR2-driven ovarian cancer progression involves upregulation of proinflammatory chemokines by potentiating NF-κB activation via EGFR-transactivated Akt signaling. Dong YL; Kabir SM; Lee ES; Son DS PLoS One; 2013; 8(12):e83789. PubMed ID: 24376747 [TBL] [Abstract][Full Text] [Related]
12. Synergistic effects of SHP2 and PI3K pathway inhibitors in GAB2-overexpressing ovarian cancer. Sun B; Jensen NR; Chung D; Yang M; LaRue AC; Cheung HW; Wang Q Am J Cancer Res; 2019; 9(1):145-159. PubMed ID: 30755818 [TBL] [Abstract][Full Text] [Related]
13. Activated STAT5 proteins induce activation of the PI 3-kinase/Akt and Ras/MAPK pathways via the Gab2 scaffolding adapter. Nyga R; Pecquet C; Harir N; Gu H; Dhennin-Duthille I; Régnier A; Gouilleux-Gruart V; Lassoued K; Gouilleux F Biochem J; 2005 Aug; 390(Pt 1):359-66. PubMed ID: 15833084 [TBL] [Abstract][Full Text] [Related]
14. Protein chip discovery of secreted proteins regulated by the phosphatidylinositol 3-kinase pathway in ovarian cancer cell lines. Moscova M; Marsh DJ; Baxter RC Cancer Res; 2006 Feb; 66(3):1376-83. PubMed ID: 16452192 [TBL] [Abstract][Full Text] [Related]
15. NF-kappa B-inducing kinase is a common mediator of IL-17-, TNF-alpha-, and IL-1 beta-induced chemokine promoter activation in intestinal epithelial cells. Awane M; Andres PG; Li DJ; Reinecker HC J Immunol; 1999 May; 162(9):5337-44. PubMed ID: 10228009 [TBL] [Abstract][Full Text] [Related]
16. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway. Chen QY; Jiao DM; Wu YQ; Chen J; Wang J; Tang XL; Mou H; Hu HZ; Song J; Yan J; Wu LJ; Chen J; Wang Z Oncotarget; 2016 Apr; 7(14):18247-61. PubMed ID: 26919096 [TBL] [Abstract][Full Text] [Related]
17. Identification of a metalloprotease-chemokine signaling system in the ovarian cancer microenvironment: implications for antiangiogenic therapy. Agarwal A; Tressel SL; Kaimal R; Balla M; Lam FH; Covic L; Kuliopulos A Cancer Res; 2010 Jul; 70(14):5880-90. PubMed ID: 20570895 [TBL] [Abstract][Full Text] [Related]
18. Blockade of nuclear factor-kappaB signaling inhibits angiogenesis and tumorigenicity of human ovarian cancer cells by suppressing expression of vascular endothelial growth factor and interleukin 8. Huang S; Robinson JB; Deguzman A; Bucana CD; Fidler IJ Cancer Res; 2000 Oct; 60(19):5334-9. PubMed ID: 11034066 [TBL] [Abstract][Full Text] [Related]
19. Keratinocyte chemoattractant (KC)/human growth-regulated oncogene (GRO) chemokines and pro-inflammatory chemokine networks in mouse and human ovarian epithelial cancer cells. Son DS; Parl AK; Rice VM; Khabele D Cancer Biol Ther; 2007 Aug; 6(8):1302-12. PubMed ID: 17712227 [TBL] [Abstract][Full Text] [Related]
20. GAB2 induces tumor angiogenesis in NRAS-driven melanoma. Yang Y; Wu J; Demir A; Castillo-Martin M; Melamed RD; Zhang G; Fukunaga-Kanabis M; Perez-Lorenzo R; Zheng B; Silvers DN; Brunner G; Wang S; Rabadan R; Cordon-Cardo C; Celebi JT Oncogene; 2013 Aug; 32(31):3627-37. PubMed ID: 22926523 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]